Jeff Yass’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,327
| Closed | -$17K | – | 12945 |
|
|
2025
Q1 | $18K | Sell |
2,327
-3,041
| -57% | -$36.5K | ﹤0.01% | 12132 |
|
|
2024
Q4 | $71.1K | Buy |
5,368
+3,154
| +142% | +$29.3K | ﹤0.01% | 11531 |
|
|
2024
Q3 | $22.1K | Sell |
2,214
-17,110
| -89% | -$258K | ﹤0.01% | 11609 |
|
|
2024
Q2 | $431K | Buy |
+19,324
| New | +$597K | ﹤0.01% | 8640 |
|
|
2024
Q1 | – | Sell |
-9,763
| Closed | -$421K | – | 12510 |
|
|
2023
Q4 | $216K | Buy |
9,763
+1,891
| +24% | +$28.5K | ﹤0.01% | 10519 |
|
|
2023
Q3 | $170K | Buy |
7,872
+6,120
| +349% | +$240K | ﹤0.01% | 10416 |
|
|
2023
Q2 | $118K | Sell |
1,752
-7,031
| -80% | -$2.91M | ﹤0.01% | 10809 |
|
|
2023
Q1 | $4.1M | Buy |
8,783
+6,202
| +240% | +$3.28M | ﹤0.01% | 3753 |
|
|
2022
Q4 | $1.03M | Sell |
2,581
-1,054
| -29% | -$404K | ﹤0.01% | 6107 |
|
|
2022
Q3 | $1.18M | Buy |
3,635
+1,147
| +46% | +$369K | ﹤0.01% | 6204 |
|
|
2022
Q2 | $657K | Sell |
2,488
-3,083
| -55% | -$788K | ﹤0.01% | 7596 |
|
|
2022
Q1 | $1.67M | Sell |
5,571
-10,248
| -65% | -$3.57M | ﹤0.01% | 5871 |
|
|
2021
Q4 | $5.58M | Buy |
15,819
+1,359
| +9% | +$423K | ﹤0.01% | 3556 |
|
|
2021
Q3 | $3.69M | Sell |
14,460
-698
| -5% | -$247K | ﹤0.01% | 4521 |
|
|
2021
Q2 | $10.1M | Buy |
15,158
+10,877
| +254% | +$6.27M | ﹤0.01% | 2905 |
|
|
2021
Q1 | $3.71M | Sell |
4,281
-2,493
| -37% | -$2.65M | ﹤0.01% | 4502 |
|
|
2020
Q4 | $6.28M | Buy |
6,774
+1,946
| +40% | +$2.05M | ﹤0.01% | 3082 |
|
|
2020
Q3 | $4.96M | Sell |
4,828
-315
| -6% | -$339K | ﹤0.01% | 3060 |
|
|
2020
Q2 | $5.21M | Sell |
5,143
-2,244
| -30% | -$2.08M | ﹤0.01% | 2950 |
|
|
2020
Q1 | $6.42M | Sell |
7,387
-6,641
| -47% | -$6.6M | ﹤0.01% | 2256 |
|
|
2019
Q4 | $15M | Buy |
14,028
+1,899
| +16% | +$1.94M | ﹤0.01% | 1682 |
|
|
2019
Q3 | $11.2M | Buy |
12,129
+3,347
| +38% | +$3.68M | ﹤0.01% | 1856 |
|
|
2019
Q2 | $9.92M | Buy |
8,782
+6,426
| +273% | +$7.03M | ﹤0.01% | 1892 |
|
|
2019
Q1 | $3.2M | Sell |
2,356
-17,013
| -88% | -$23.1M | ﹤0.01% | 3037 |
|
|
2018
Q4 | $22.4M | Buy |
19,369
+13,370
| +223% | +$15M | 0.01% | 1003 |
|
|
2018
Q3 | $9.11M | Sell |
5,999
-529
| -8% | -$815K | ﹤0.01% | 2033 |
|
|
2018
Q2 | $10.2M | Sell |
6,528
-1,153
| -15% | -$1.5M | ﹤0.01% | 1915 |
|
|
2018
Q1 | $8.87M | Sell |
7,681
-4,804
| -38% | -$6.33M | ﹤0.01% | 1901 |
|
|
2017
Q4 | $14.8M | Buy |
12,485
+10,086
| +420% | +$12.6M | 0.01% | 1491 |
|
|
2017
Q3 | $3.23M | Sell |
2,399
-527
| -18% | -$555K | ﹤0.01% | 3121 |
|
|
2017
Q2 | $2.36M | Buy |
2,926
+1,790
| +158% | +$1.25M | ﹤0.01% | 3606 |
|
|
2017
Q1 | $700K | Sell |
1,136
-3,708
| -77% | -$2.26M | ﹤0.01% | 5872 |
|
|
2016
Q4 | $2.59M | Buy |
+4,844
| New | +$2.42M | ﹤0.01% | 3522 |
|
|
2016
Q2 | – | Sell |
-601
| Closed | -$275K | – | 8748 |
|
|
2016
Q1 | $320K | Sell |
601
-3,028
| -83% | -$1.51M | ﹤0.01% | 7157 |
|
|
2015
Q4 | $2.76M | Buy |
+3,629
| New | +$2.41M | ﹤0.01% | 3444 |
|
|
2015
Q1 | – | Sell |
-799
| Closed | -$546K | – | 9550 |
|
|
2014
Q4 | $546K | Buy |
+799
| New | +$514K | ﹤0.01% | 7044 |
|
Other funds holding KYNB
AC
BC
Jeff Yass's KYNB Position: Q2 2025 in Review
Jeff Yass sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 2,327 shares — an estimated $17K sold.
Jeff Yass first reported a position in KYNB in Q4 2014 and held it in 36 quarters. The position peaked at $22.4M in Q4 2018. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.
- Jeff Yass reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
- Jeff Yass sold 2,327 Kyntra Bio shares in Q2 2025, an estimated $17K.
- Jeff Yass first reported a position in Kyntra Bio in Q4 2014 and held it in 36 quarters.
- Jeff Yass's Kyntra Bio position peaked at $22.4M in Q4 2018.
- 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.